Изучение иммунологической активности и реактогенности вакцины «ЭнцеВир®» при иммунизации взрослых по экспресс-схеме

Comparative assessment of express-scheme (0.14) vaccination against forest-spring encephalitis using vaccines "EnceVirR" (FGUP SMS Microgen, branch NPO Virion Tomsk, Russia) and FSMEImmun RInject (Baxter, Austria) aimed at assessing their immunologic activity and reactogeneity was performed on volunteers of both sexes aged 1870 years. Serocoversion for EnceVirR vaccine was 98% (on the 14-th and 30-th days after vaccination) and those for FSME-Immun vaccine were 86% (on the 14-th day) and 96% (on the 30-th day after vaccination).